Company / Operating Income per Share
Voyager Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$2.23
FY2025
5-year range
-$1.91 / $2.23
FY2021-FY2025
Trend
+293.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed +293% YoY in FY2025, a notable deviation from the 9-year average annual change of -2%.
Based on SEC 10-K filings.
2.23 in FY2025 with a 3-year CAGR of +45.6%.
Improved from $-1.91 to $2.23 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +45.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 293.1% year-over-year.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.23 | +293.1% |
| FY2024 | -$1.15 | +39.5% |
| FY2023 | -$1.91 | -364.0% |
| FY2022 | $0.72 | +152.2% |
| FY2021 | -$1.38 | +44.0% |
| FY2020 | -$2.47 | -11.3% |
| FY2019 | -$2.22 | -69.7% |
| FY2018 | -$1.31 | -65.3% |
| FY2017 | -$0.79 | -37.3% |
| FY2016 | -$0.58 | +87.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026